MRI-Based Use of Neoadjuvant Chemoradiotherapy in Rectal Carcinoma: Surgical Quality and Histopathological Outcome of the OCUM Trial-Reference-Cited by-同舟云学术

MRI-Based Use of Neoadjuvant Chemoradiotherapy in Rectal Carcinoma: Surgical Quality and Histopathological Outcome of the OCUM Trial

Published:2019-08-14 Issue:2 Volume:27 Page:417-427
ISSN:1068-9265
Container-title:Annals of Surgical Oncology
language:en
Short-container-title:Ann Surg Oncol

Author:

Kreis Martin E., ,Ruppert Reinhard,Kube Rainer,Strassburg Joachim,Lewin Andreas,Baral Joerg,Maurer Christoph A.,Sauer Joerg,Winde Günther,Thomasmeyer Rena,Stelzner Sigmar,Bambauer Cornelius,Scheunemann Soenke,Faedrich Axel,Junginger Theodor,Hermanek Paul,Merkel Susanne

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Surgery

Link

http://link.springer.com/content/pdf/10.1245/s10434-019-07696-y.pdf

Reference38 articles.

1. Wibe A, Moller B, Norstein J, Carlsen E, Wiig JN, Heald RJ, et al. A national strategic change in treatment policy for rectal cancer—implementation of total mesorectal excision as routine treatment in Norway. A national audit. Dis Colon Rectum 2002;45:857–66.

2. Peeters KC, Marijnen CA, Nagtegaal ID, Kranenbarg EK, Putter H, Wiggers T, et al. The TME trial after a median follow-up of 6 years. Increased local control but no survival benefit in irradiated patients with resectable rectal carcinoma. Ann Surg. 2007;246:693–701.

3. Sebag-Montefiore D, Stephens RJ, Steele R, Monson J, Grieve R, Khanna S, et al. Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR 07 and NCIC CTG C016): a multicentre, randomised trial. Lancet 2009;373:811–20.

4. Peeters KC, van de Velde CJ, Leer JW, Martijn H, Junggeburt JM, Kranenbarg EK, et al. Late side effects of short-course preoperative radiotherapy combined with total mesorectal excision for rectal cancer: increased bowel dysfunction in irradiated patients: a Dutch Colorectal Cancer Group study. J Clin Oncol. 2005;23:6199–206.

5. Marijnen CA, van de Velde CJ, Putter H, van den Brink M, Maas CP, Martijn H, et al. Impact of short-term preoperative radiotherapy on health-related quality of life and sexual functioning in primary rectal cancer: report of a multicentre randomized trial. J Clin Oncol. 2005;23:1847–58.

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rektumkarzinom: Indikationen zur neoadjuvanten und adjuvanten Therapie;Springer Reference Medizin;2024

2. A contemporary assessment of total neoadjuvant therapy (TNT) protocols for locally advanced rectal cancer: adoption and expert perspectives at German Cancer Society (DKG)-certified colorectal cancer centers;Journal of Cancer Research and Clinical Oncology;2023-07-12

3. Comment on “Neoadjuvant Chemotherapy With CAPOX Versus Chemoradiation for Locally Advanced Rectal Cancer With Uninvolved Mesorectal Fascia (CONVERT): Initial Results of a Phase III Trial” by Mei et al.: Two Overtreatments Compared;Annals of Surgery Open;2023-06

4. Rectal Cancer and Radiation in Colitis;Clinics in Colon and Rectal Surgery;2023-02-22

5. Improving Value in Surgery: Opportunities in Rectal Cancer Care. A Surgical Perspective;Annals of Surgery;2022-11-04